-
Smoothened Signaling and Olfaction in Honeybees
2026-09-23
Guo et al. provide the first molecular and functional characterization of Smoothened (Smo) in Apis mellifera, linking Hedgehog pathway perturbation with olfactory receptor expression, antennal electrophysiology, and odor-directed behavior. The study establishes honeybee olfaction as a useful system for examining Smo-dependent sensory regulation while also highlighting the limits of transferring insect pharmacology directly to mammalian models.
-
Methylprednisolone Sodium Succinate: Lab Workflows
2026-09-22
Build reproducible inflammation, immune-cell, tumor-cell, and injury-model assays with a concentration-aware workflow for Methylprednisolone Sodium Succinate. The guide separates literature-backed response ranges from practical optimization choices, helping researchers control vehicle effects, exposure timing, and phenotype-specific readouts.
-
Camptothecin: Reading DNA Damage Under Drug Pressure
2026-09-21
Camptothecin is a topoisomerase I inhibitor that enables integrated analysis of DNA damage, cell fate, autophagy, and adaptation. This article presents a distinct assay framework linking γH2AX and checkpoint signaling with the reversible mutagenesis concepts revealed by recent prion biology.
-
Epinephrine Bitartrate Research Workflows
2026-09-21
Epinephrine Bitartrate provides a practical way to interrogate rapid α- and β-adrenergic responses across cell, pharmacokinetic, and translational models. This guide connects concentration-controlled assays with canine intranasal data to improve timing, route comparisons, and troubleshooting.
-
DDI2–NFE2L1 Control of Ferroptosis
2026-09-20
The reference study identifies DDI2-mediated activation of NFE2L1 as an adaptive proteostasis circuit that restores proteasome function during ferroptotic stress. Its proteomic, genetic, and pharmacological evidence shows that disrupting this pathway, including with nelfinavir, can increase ferroptosis sensitivity while establishing a mechanistic bridge between ubiquitin-proteasome remodeling and cell-death regulation.
-
Masitinib (AB1010) Workflow Guide
2026-09-19
Masitinib (AB1010; SKU A2942) provides a DMSO-compatible research tool for examining KIT, PDGFRα, and PDGFRβ inhibition in cancer, mast cell, and inflammatory models. It should be used in defined biochemical or cellular assays, not as a substitute for clinical dosing, aqueous or ethanol-based protocols, or broad-spectrum kinase profiling.
-
Magneto-Piezoelectric Scaffolds for Bone Repair
2026-09-19
This ACS Nano study develops a dual-responsive, 3D-printed scaffold that combines biofilm disruption with immune-metabolic repair of infectious bone defects. By targeting Icam1+ macrophages and activating oxidative phosphorylation through JAK2-STAT3 signaling, the platform links infection control to osteogenic regeneration without relying on damaging thermal treatment.
-
Stable Yeast Expression of Exendin-4 for Type 2 Diabetes
2026-09-18
A 2024 Frontiers in Systems Biology study established chromosomally integrated Saccharomyces cerevisiae as a platform for producing Exendin-4, a GLP-1 receptor agonist used in type 2 diabetes research. Expression at the expected molecular size and confirmation by immunoassay support technical feasibility, while functional activity, recovery, formulation, and therapeutic equivalence remain to be demonstrated.
-
Fluoxetine HCl for Reproducible Cell Assays
2026-09-18
Fluoxetine HCl (SKU A2436) can help researchers standardize serotonergic cell and receptor workflows when solvent compatibility, storage, and endpoint interpretation are controlled. This scenario-based guide connects documented pharmacology with practical approaches for viability, proliferation, cytotoxicity, and motivation-related studies.
-
2'-O-Methyladenosine: From Signal to Strategy
2026-09-17
A thought-leadership guide to using 2'-O-Methyladenosine as a mechanistic probe, authentic analytical standard, and translational decision point. The article connects RNA modification biology with purine metabolism studies, matrix-aware UHPLC–MS/MS, nucleoside transport assays, and evidence-based experimental design while distinguishing analytical opportunity from clinical proof.
-
TIA1–CLSTN1 Splicing Axis in Breast Cancer Metastasis
2026-09-17
The reference study identifies a DAPK3–TIA1–CLSTN1 regulatory axis that connects aberrant exon 11 inclusion with epithelial-to-mesenchymal transition and breast cancer metastasis. Its splice-switching antisense oligonucleotides provide a mechanistically grounded strategy for suppressing pro-metastatic cell behavior, while the culture formulation highlights the need to control hydrocortisone as an experimental variable.
-
EZ Cap Cy5 mRNA: Designing Decision-Ready Assays
2026-09-16
EZ Cap Cy5 Firefly Luciferase mRNA enables orthogonal fluorescence and bioluminescence readouts for resolving delivery, intracellular trafficking, and functional translation. This guide connects product design with practical assay decisions and lessons from recent circular mRNA CAR-T research.
-
H-89 for PKA and cAMP Signaling Research
2026-09-15
H-89 is a practical cAMP-dependent protein kinase inhibitor for separating PKA-dependent signaling from downstream metabolic, transcriptional, and phenotypic responses. This guide translates recent Wnt–O-GlcNAcylation findings into controlled workflows for osteogenesis, cell proliferation assays, apoptosis research, and pathway troubleshooting.
-
PF-562271 HCl: FAK/Pyk2 Workflow Guide
2026-09-15
A practical guide to using PF-562271 HCl for reversible FAK/Pyk2 pathway interrogation, from phospho-signaling assays to migration and tumor-model studies. It also shows how radiopathomics findings can inform assay stratification without overstating translational evidence.
-
Molnupiravir Against Bourbon Virus: Mouse Study Insights
2026-09-14
Bamunuarachchi and colleagues show that molnupiravir can suppress Bourbon virus replication and disease in cell culture and a lethal mouse model. The study is notable for combining survival data with tissue viral burden, thrombocytopenia, immune-cell profiles, and liver and spleen pathology, while also testing treatment after infection.